Craig Gilgallon
Fondatore presso Cingulate Works, Inc.
Patrimonio netto: 8 183 $ in data 30/04/2024
Profilo
Craig Steven Gilgallon is the founder of Cingulate Works, Inc. (founded in 2013) and Cingulate, Inc. (founded in 2013).
He held the titles of Secretary, Executive VP & General Counsel at both companies.
Mr. Gilgallon is also the founder of Cingulate Therapeutics LLC.
Mr. Gilgallon's current job is as a Partner at Pawar Gilgallon & Rudy LLC (since 2012).
Mr. Gilgallon's education history includes an undergraduate degree from Ithaca College and a graduate degree from Thomas Jefferson School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CINGULATE, INC.
0.24% | 15/04/2024 | 9 742 ( 0.24% ) | 8 183 $ | 30/04/2024 |
Posizioni attive di Craig Gilgallon
| Società | Posizione | Inizio |
|---|---|---|
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Fondatore | 01/01/2013 |
| Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01/01/2012 |
Precedenti posizioni note di Craig Gilgallon
| Società | Posizione | Fine |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Fondatore | 15/12/2023 |
| CINGULATE INC. | Fondatore | 15/12/2023 |
Formazione di Craig Gilgallon
| Ithaca College | Undergraduate Degree |
| Thomas Jefferson School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
| Pawar Gilgallon & Rudy LLC | |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
- Borsa valori
- Insiders
- Craig Gilgallon
